|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM301464057 |
| 003 |
DE-627 |
| 005 |
20231225104657.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231225s2019 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1002/adma.201904329
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1004.xml
|
| 035 |
|
|
|a (DE-627)NLM301464057
|
| 035 |
|
|
|a (NLM)31538379
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Wang, Cong
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Advanced Nanotechnology Leading the Way to Multimodal Imaging-Guided Precision Surgical Therapy
|
| 264 |
|
1 |
|c 2019
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 10.04.2020
|
| 500 |
|
|
|a Date Revised 30.09.2020
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
|
| 520 |
|
|
|a Surgical resection is the primary and most effective treatment for most patients with solid tumors. However, patients suffer from postoperative recurrence and metastasis. In the past years, emerging nanotechnology has led the way to minimally invasive, precision and intelligent oncological surgery after the rapid development of minimally invasive surgical technology. Advanced nanotechnology in the construction of nanomaterials (NMs) for precision imaging-guided surgery (IGS) as well as surgery-assisted synergistic therapy is summarized, thereby unlocking the advantages of nanotechnology in multimodal IGS-assisted precision synergistic cancer therapy. First, mechanisms and principles of NMs to surgical targets are briefly introduced. Multimodal imaging based on molecular imaging technologies provides a practical method to achieve intraoperative visualization with high resolution and deep tissue penetration. Moreover, multifunctional NMs synergize surgery with adjuvant therapy (e.g., chemotherapy, immunotherapy, phototherapy) to eliminate residual lesions. Finally, key issues in the development of ideal theranostic NMs associated with surgical applications and challenges of clinical transformation are discussed to push forward further development of NMs for multimodal IGS-assisted precision synergistic cancer therapy
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Review
|
| 650 |
|
4 |
|a multimodal imaging
|
| 650 |
|
4 |
|a nanomaterials
|
| 650 |
|
4 |
|a nanotechnology
|
| 650 |
|
4 |
|a precision surgery
|
| 650 |
|
4 |
|a synergistic therapy
|
| 700 |
1 |
|
|a Fan, Wenpei
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Zhang, Zijian
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Wen, Yu
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Xiong, Li
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chen, Xiaoyuan
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 31(2019), 49 vom: 13. Dez., Seite e1904329
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
| 773 |
1 |
8 |
|g volume:31
|g year:2019
|g number:49
|g day:13
|g month:12
|g pages:e1904329
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.201904329
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 31
|j 2019
|e 49
|b 13
|c 12
|h e1904329
|